Search bioRxivSearch

Biology subjects

Kriegstein, A. R.

Publications and source records attributed to Kriegstein, A. R..

3 recordsLinked to original sources

Regulation of Cell-Type-Specific Transcriptomes by miRNA Networks During Human Brain Development

MicroRNAs (miRNAs) regulate many cellular events by regulating hundreds of mRNA transcripts. However, it is unclear how miRNA-mRNA interactions are contextualized into the framework of transcriptional heterogeneity among closely related cells of the developing human brain. By combining the multiple complementary approaches, AGO2-HITS-CLIP, single-cell profiling and bipartite network analysis, we show that the miRNA-mRNA network operates as functional modules related to cell-type identities and undergo dynamic transitions during brain development.

developmental biology

Saturating Single-Cell Datasets

High throughput methods for profiling the transcriptomes of single cells have recently emerged as transformative approaches for large-scale population surveys of cellular diversity in heterogeneous primary tissues. Efficient generation of such an atlas will depend on sufficient sampling of the diverse cell types while remaining cost-effective to enable a comprehensive examination of organs, developmental stages, and individuals. To examine the relationship between cell number and transcriptional heterogeneity in the context of unbiased cell type classification, we explicitly explored the population structure of a publically available 1.3 million cell dataset from the E18.5 mouse brain. We propose a computational framework for inferring the saturation point of cluster discovery in a single cell mRNA-seq experiment, centered around cluster preservation in downsampled datasets. In addition, we introduce a \"complexity index\", which characterizes the heterogeneity of cells in a given dataset. Using Cajal-Retzius cells as an example of a limited complexity dataset, we explored whether biological distinctions relate to technical clustering. Surprisingly, we found that clustering distinctions carrying biologically interpretable meaning are achieved with far fewer cells (20,000). Together, these findings suggest that most of the biologically interpretable insights from the 1.3 million cells can be recapitulated by analyzing 50,000 randomly selected cells, indicating that instead of profiling few individuals at high \"cellular coverage\", the much anticipated cell atlasing studies may instead benefit from profiling more individuals, or many time points at lower cellular coverage.\n\nRecent efforts seek to create a comprehensive cell atlas of the human body1,2 Current technology, however, makes it precipitously expensive to perform analysis of every cell. Therefore, designing effective sampling strategies be critical to generate a working atlas in an efficient, cost-effective, and streamlined manner. The advent of single cell and single nucleus mRNA sequencing (RNAseq) in droplet format3,4 now enables large scale sampling of cells from any tissue, and a recently released publicly available dataset of 1.3 million single cells from the E18.5 mouse brain generated with the 10X Chromium5 provides an opportunity to explore the relationship between population structure and the number of sampled cells necessary to reveal the underlying diversity of cell types. Here, we present a framework for how researchers can evaluate whether a dataset has reached saturation, and we estimate how many cells would be required to generate an atlas of the sample analyzed here. This framework can be applied to any organ or cell type specific atlas for any organism.

bioinformatics

Limited contribution of rare, noncoding variation to autism spectrum disorder from sequencing of 2,076 genomes in quartet families

Genomic studies to date in autism spectrum disorder (ASD) have largely focused on newly arising mutations that disrupt protein coding sequence and strongly influence risk. We evaluate the contribution of noncoding regulatory variation across the size and frequency spectrum through whole genome sequencing of 519 ASD cases, their unaffected sibling controls, and parents. Cases carry a small excess of de novo (1.02-fold) noncoding variants, which is not significant after correcting for paternal age. Assessing 51,801 regulatory classes, no category is significantly associated with ASD after correction for multiple testing. The strongest signals are observed in coding regions, including structural variation not detected by previous technologies and missense variation. While rare noncoding variation likely contributes to risk in neurodevelopmental disorders, no category of variation has impact equivalent to loss-of-function mutations. Average effect sizes are likely to be smaller than that for coding variation, requiring substantially larger samples to quantify this risk.

genomics